Legal & General Group’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$57.5K Sell
2,330
-401
-15% -$7.01K ﹤0.01% 2656
2025
Q4
$46.2K Sell
2,731
-121
-4% -$2.13K ﹤0.01% 2746
2025
Q3
$62K Hold
2,852
﹤0.01% 2693
2025
Q2
$40.6K Buy
+2,852
New +$45.1K ﹤0.01% 2751
2021
Q2
Sell
-1,838
Closed -$13K 3541
2021
Q1
$13K Hold
1,838
﹤0.01% 3305
2020
Q4
$15K Hold
1,838
﹤0.01% 3195
2020
Q3
$15K Sell
1,838
-551
-23% -$3.76K ﹤0.01% 3071
2020
Q2
$13K Buy
+2,389
New +$11.9K ﹤0.01% 3236

Other funds holding ETON

Legal & General Group's ETON Position: Q1 2026 in Review

Legal & General Group reduced its Eton Pharmaceutcials (ETON) stake by 15% in Q1 2026, selling an estimated $7.01K and leaving 2,330 shares worth $57.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2656.

Legal & General Group first reported a position in ETON in Q2 2020 and has held it in 8 quarters since. The position peaked at $62K in Q3 2025. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • Legal & General Group held 2,330 shares of Eton Pharmaceutcials worth $57.5K as of Q1 2026.
  • Legal & General Group sold 401 Eton Pharmaceutcials shares in Q1 2026, an estimated $7.01K.
  • Eton Pharmaceutcials made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2656 holding.
  • Legal & General Group first reported a position in Eton Pharmaceutcials in Q2 2020 and has held it in 8 quarters since.
  • Legal & General Group's Eton Pharmaceutcials position peaked at $62K in Q3 2025.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.